Arrotex Pharmaceuticals in conjunction with PharmaPrograms recognise the increased workload to support your patients with the switch to an Arrotex supplied brand of adalimumab. We are pleased to provide additional value to your pharmacy with the 50 for 50 offer.
During the period 1 July and 30 September 2021, if your pharmacy reaches 50% substitution with the Arrotex supplied brand of adalimumab, Arrotex Pharmaceuticals will provide $50.00 for every Arrotex Biologics Pharmacy Program claim of adalimumab, made between 1 July to 31 December 2021.*
THERE ARE ALREADY OVER 400 ENROLLED PHARMACIES THAT ARE SUBSTITUTING OVER 50%
The additional $25.00 per claim recognises the additional time, support and training you offer to your patients when switching.
This program is facilitated by PharmaPrograms and are available to answer any questions you have on 1300 377 781 or email email@example.com. Alternatively, you can contact your Arrotex Territory Manager for further details regarding this promotion.
*Calculations will be based on data available to Arrotex from your dispensing software provider for the period of 1 July 2021 through to the 31 December 2021.